Global Orthobiologics
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Orthobiologics market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Orthobiologics market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Product Segment Analysis | Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, BMAC |
| Application Segment Analysis | Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, Maxillofacial and Dental Applications |
| End-user Segment Analysis | Hospitals, Orthopedic Clinics, and Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities |
|---|---|
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Orthobiologics Market Report 2025.
The Orthobiologics market was valued at USD 6.06 billion in 2022 and will reach USD 9.37 billion by 2030, registering a CAGR of 5.6 % for the forecast period 2023-2030.
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Orthobiologics Market Sales Revenue | xxxx | xxxx | xxxx | 5.6% |
Orthobiologics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Orthobiologics consist of organic and synthetic materials which are helpful in curing musculoskeletal problems, curing bone and soft tissue lesions, and orthopaedic surgeries. Orthobiologics is also recognized as regenerative cellular therapies. Orthobiologics comes under orthopedic surgery, including platelet-rich plasma, bone marrow aspirate, mesenchymal stem cells, and extracellular matrix. Mainly skilled professionals like orthopedic surgeons have the information regarding the contemporary ortho-biologics so they can use it correctly in their studies. The scientific reason for studying the importance of orthobiologics is it increases the chances of healing tissues with the help of cartilage, tendons, muscle, bone, ligaments, and meniscus.
Orthopedic injuries mainly consist of some serious injuries such as violent attacks, serious accidents, or injuries related to bones, ligaments, muscles, tendons, cartilage, and joints. According to the American Academy of Orthopedic Surgeons, more than 6.8 million patients suffering from orthopedic injuries come to medical attention every year. There are also injuries that affect the joints of the body such as dislocation, fractures, sprains, impingement, and hernia. All these increasing injuries mainly affect the elderly population. The aged population is more prone to diseases such as compression fractures, osteoporosis, and other conditions. In this way, there is an increase in the demand for orthopedic injuries that helps increase the global orthobiologics market.
Several studies have confirmed that there are adverse effects associated with the clinical use of the bone morphogenetic protein. Some of the side effects are postoperative inflammation, cervical spine swelling, and potentially life-threatening complications. BMPs are members of the TGF-β superfamily that act as a regulator during embryogenesis and are used for bone or cartilage formation. As there are some limitations associated with bone graft substitutes, they are expected to restrain the overall market growth.
COVID-19 had a negative impact on the orthobiologics market. There was a decrease in the demand for orthobiologics products which led to a decrease in the population of the patient. There was a decrease in orthobiologic products because of the decreasing number of patient visits, outpatient settings, and emergency care, and a decrease in supply chain challenges reducing the sales of the orthobiologics market. During the pandemic, there were problem-related to the transportation of drugs from one place to another which decreased the demand of the orthobiologics market.
We have various report editions of Orthobiologics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.
Allomend launched the Acellular Dermal Matrix, the newest addition to the AlloMend product line.
AlloSource was one of the largest allograft providers which had innovative cellular and tissue products to help surgeons heal their patients with the help of the AlloMend product line. The company grew because of the country's largest tissue networks, creating more than 200 bone and soft tissue allograft types.
Bone Biologics had a partnership with MTF to supply DBM.
Bone Biologics was a developing bone graft substitute product that consisted of a growth factor and was supplied by MTF for the initiation and improvement of bone formation. They had a target of developing a product with special features and benefits.
Top Companies Market Share in Orthobiologics Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Johnson and Johnson | xxxx | xxxx | xxxx | xxxx |
| Wright Medical Group | xxxx | xxxx | xxxx | xxxx |
| Globus Medical Inc. | xxxx | xxxx | xxxx | xxxx |
| Medline Industries | xxxx | xxxx | xxxx | xxxx |
| Stryker Corporation | xxxx | xxxx | xxxx | xxxx |
| Zimmer Biomet Holdings | xxxx | xxxx | xxxx | xxxx |
| Anika Therapeutics | xxxx | xxxx | xxxx | xxxx |
| MTF Biologics | xxxx | xxxx | xxxx | xxxx |
| Sano Orthopedics | xxxx | xxxx | xxxx | xxxx |
| Alphatec Spine Inc | xxxx | xxxx | xxxx | xxxx |
| Bone Biologics Corporation | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The Orthobiologics market is further segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa region. The largest share of this segment is acquired by the North American region. Due to increasing bone-related injuries or disorders, there is a demand for synthetic products that will help to drive market growth. The main target is to focus on R&D investment and research activities for carrying out bone grafting procedures. According to the CDC, it was stated that around 54 million people were diagnosed with arthritis and nearly 78 million people suffering from arthritis are expected to increase the market.
The current report Scope analyzes Orthobiologics Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Orthobiologics Market is witnessing significant growth in the near future.
In 2023, the Viscosupplementation Products segment accounted for noticeable share of global Orthobiologics Market and is projected to experience significant growth in the near future.
The Osteoarthritis and Degenerative Arthritis segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Johnson and Johnson , Globus Medical Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Research Analyst
LinkedIn | Profile | Book Appointment
Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.
Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Orthobiologics Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Orthobiologics Industry growth. Orthobiologics market has been segmented with the help of its Product, Application End-user, and others. Orthobiologics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The viscosupplementation market is expected to hold the largest market share from the years 2023-2030
The product section is further divided into viscosupplementation products, DBM, synthetic orthobiologics, BMP, allografts, PRP, and BMAC. The viscosupplementation market is expected to hold the largest market share of orthobiologics because of increasing cases of osteoarthritis of knee and hip joints. Osteoarthritis of the knee is the leading cause of disability and is treated with nonsurgical methods. It contains naturally occurring substances such as hyaluronic acid that are injected into joints. And in this way, it reduces the pain and helps in the process of movement. Therefore, there is significant growth in the viscosupplementation product as it is an effective treatment and has long-term effects.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Orthobiologics Industry. Request a Free Sample PDF!
The osteoarthritis and degenerative arthritis account for the largest revenue share during the forecast period
On the basis of application, it is further divided into osteoarthritis and degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, maxillofacial, and dental applications. Osteoarthritis and degenerative arthritis account for the largest share due to the rising target patient population across the markets. Degenerative arthritis is a chronic disorder that damages cartilage and tissue surrounding the joint. Osteoarthritis is characterized by symptoms such as swelling, pain, and stiffness. Therefore, increased clinical advancement and improved healthcare facilities increase the market for osteoarthritis and degenerative arthritis.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to have the largest market share during the forecast period.
This segment is further divided into hospitals, orthopedic clinics and ambulatory care centers, research and academic institutes, dental clinics, and facilities. Hospitals, orthopedic clinics, and ambulatory care centers have the largest market share because of the increasing number of spinal fusion surgeries. There are an increasing number of patients visiting for orthopedic procedures in the hospital segment. There is also an increasing number of specialty clinics in order to carry out the treatment of bone defects and other orthopedic surgeries. Thus, there is a significant increase in the demand for clinics and centers.
Disclaimer:
| Product | Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, BMAC |
| Application | Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, Maxillofacial and Dental Applications |
| End-user | Hospitals, Orthopedic Clinics, and Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities |
| List of Competitors | Johnson and Johnson, Wright Medical Group, Globus Medical Inc., Medline Industries, Stryker Corporation, Zimmer Biomet Holdings, Anika Therapeutics, MTF Biologics, Sano Orthopedics, Alphatec Spine Inc, Bone Biologics Corporation |
Chapter 1 2026 Geopolitical Outlook - Orthobiologics Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Orthobiologics. Further deep in this chapter, you will be able to review Global Orthobiologics Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Orthobiologics. Further deep in this chapter, you will be able to review North America Orthobiologics Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Orthobiologics. Further deep in this chapter, you will be able to review Europe Orthobiologics Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Orthobiologics. Further deep in this chapter, you will be able to review Asia Pacific Orthobiologics Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Orthobiologics. Further deep in this chapter, you will be able to review South America Orthobiologics Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Orthobiologics. Further deep in this chapter, you will be able to review Middle East Orthobiologics Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Orthobiologics. Further deep in this chapter, you will be able to review Middle East Orthobiologics Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Orthobiologics. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End-user Analysis 2022 - 2034
Chapter 15 Orthobiologics Price Trend Analysis
Chapter 16 Orthobiologics Import/Export Analysis
Chapter 17 Orthobiologics Production Analysis
Chapter 18 Gap Analysis
Chapter 19 Strategy Analysis
Chapter 20 Profitability and Gross Margin Analysis
Chapter 21 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Orthobiologics market
Chapter 22 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 23 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.